ConductScience.org, home

Paper41233335

Depressive symptomatology in the first-episode schizophrenia spectrum disorders OPTiMiSE trial: prevalence, correlates, symptom progression and outcomes.

Lopez-Morinigo JD and 8 others. Schizophrenia (Heidelb), 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Depressive symptomatology in the first-episode schizophrenia spectrum disorders OPTiMiSE trial: prevalence, correlates, symptom progression and outcomes. Papers, record 41233335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41233335

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Depressive symptomatology in the first-episode schizophrenia spectrum disorders OPTiMiSE trial: prevalence, correlates, symptom progression and outcomes.
PubMed
Journal
Schizophrenia (Heidelb)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-09-18
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lopez-Morinigo JDJavier-Davidhttps://orcid.org/0000-0002-4264-2664
2Fraguas DDavid
3Diaz-Caneja CMCovadonga Mhttps://orcid.org/0000-0001-8538-3175
4Galvañ JJoaquinhttps://orcid.org/0009-0006-6195-570X
5Berger GGregorhttps://orcid.org/0000-0003-2030-141X
6Leucht SStefanhttps://orcid.org/0000-0002-4934-4352
7Rossum IWInge Winter-van
8Arango CCelsohttps://orcid.org/0000-0003-3382-4754
9Moreno CCarmenhttps://orcid.org/0000-0003-0541-4846

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
HEALTH-F2-2010-242114European Commission (EC)PubMed
HEALTH-F2-2010-242114European Commission (EC)PubMed
HEALTH-F2-2010-242114European Commission (EC)PubMed
HEALTH-F2-2010-242114European Commission (EC)PubMed
HEALTH-F2-2010-242114European Commission (EC)PubMed
HEALTH-F2-2010-242114European Commission (EC)PubMed
HEALTH-F2-2010-242114European Commission (EC)PubMed
HEALTH-F2-2010-242114European Commission (EC)PubMed

Source PubMed

Download CSV of grants

References77

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111102326Cognitive approach to depression and suicidal thinking in psychosis. 1. Ontogeny of post-psychotic depression.Br J Psychiatry2000https://conductscience.org/library/papers/11102326PubMed
238691387Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial.JAMA Psychiatry2024https://conductscience.org/library/papers/38691387PubMed
333069317Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.Lancet Psychiatry2020https://conductscience.org/library/papers/33069317PubMed
440268731Mental health status of the European population and its determinants: A cross-national comparison study.Eur Psychiatry2025https://conductscience.org/library/papers/40268731PubMed
510782554Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning.Acta Psychiatr Scand2000https://conductscience.org/library/papers/10782554PubMed
621568628Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.World J Biol Psychiatry2012https://conductscience.org/library/papers/21568628PubMed
719922525The evolution of depression and suicidality in first episode psychosis.Acta Psychiatr Scand2010https://conductscience.org/library/papers/19922525PubMed
834942142The neuropsychiatry of Parkinson's disease: advances and challenges.Lancet Neurol2022https://conductscience.org/library/papers/34942142PubMed
929431197Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia.Acta Psychiatr Scand2018https://conductscience.org/library/papers/29431197PubMed
102278986A depression rating scale for schizophrenics.Schizophr Res1990https://conductscience.org/library/papers/2278986PubMed
1135546936Depressive Symptoms and PANSS Symptom Dimensions in Patients With Predominant Negative Symptom Schizophrenia: A Network Analysis.Front Psychiatry2022https://conductscience.org/library/papers/35546936PubMed
129881538The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.J Clin Psychiatry1998https://conductscience.org/library/papers/9881538PubMed
1316005381Schizophrenia and depression: challenging the paradigm of two separate diseases--a controlled study of schizophrenia, depression and healthy controls.Schizophr Res2005https://conductscience.org/library/papers/16005381PubMed
1430115598Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.Lancet Psychiatry2018https://conductscience.org/library/papers/30115598PubMed
158866775A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables.Int Clin Psychopharmacol1995https://conductscience.org/library/papers/8866775PubMed
1620118450The Kraepelinian dichotomy - going, going... but still not gone.Br J Psychiatry2010https://conductscience.org/library/papers/20118450PubMed
1727421793Depression and Schizophrenia: Cause, Consequence, or Trans-diagnostic Issue?Schizophr Bull2017https://conductscience.org/library/papers/27421793PubMed
1822627166Treatment of depression in first episode of schizophrenia: results from EUFEST.Eur Neuropsychopharmacol2012https://conductscience.org/library/papers/22627166PubMed
1933271709Depression in schizophrenia: Prevalence and its impact on quality of life, disability, and functioning.Asian J Psychiatr2020https://conductscience.org/library/papers/33271709PubMed
2031964558Depressive symptoms during first episode psychosis and functional outcome: A systematic review and meta-analysis.Schizophr Res2020https://conductscience.org/library/papers/31964558PubMed

See all 77 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42169702Changes in insight and outcome over the early course of first-episode psychosis. The OPTiMiSE trial.Schizophr Res Cogn2026https://conductscience.org/library/papers/42169702PubMed
41712510Identifying Transdiagnostic Predictors of Depression across Psychoses: Informing Stratified Antidepressant Treatments.Psychother Psychosom2026https://conductscience.org/library/papers/41712510PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41233335

GET https://conductscience.org/api/papers/v1/41233335/references?page=2